Sands Capital Alternatives, LLC
ARLINGTON, VA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$694.7M2026 Q3
Positions24
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.81.3%
What Changed This Quarter?
Top Holdings
ALMR
Alamar Biosciences
20.8%
NU
Nu
12.7%
BBNX
Beta Bionics
10.9%
SGP
SpyGlass Pharma
9.4%
KVYO
Klaviyo
8.7%
TXG
10x Genomics
6.3%
IKT
Inhibikase Therapeutics
3.9%
CBRS
Cerebras Systems
3.1%
New / Increased
1 new · 2 increased
FRNMNEW
Freenome
2.7%
CBRS
Cerebras Systems
3.1%
+273.1%
BBNX
Beta Bionics
10.9%
+7.8%
Reduced / Exited
10 reduced · 1 sold out
DDOG
Datadog
2.5%
-22.1%
IOT
Samsara
2.2%
-23.3%
DASH
DoorDash
2.8%
-15.9%
KVYO
Klaviyo
8.7%
-2.6%
TOST
Toast
1.3%
-13.7%
FIGEXIT
Figma
0.1%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.